|
2012 Journal Article Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trialBeith, Jane M., Oh, Byeongsang, Chatfield, Mark D., Davis, Esther and Venkateswaran, Ramya (2012). Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trial. Medical Acupuncture, 24 (4), 241-248. doi: 10.1089/acu.2012.0876 |
|
2012 Journal Article Dietary iron is associated with memory in midlife: longitudinal cohort studyRickard, Anna P., Chatfield, Mark D., Powell, Jonathan J., Stephen, Alison M. and Richards, Marcus (2012). Dietary iron is associated with memory in midlife: longitudinal cohort study. Journal of Pharmacy and Nutrition Sciences, 2 (1), 57-62. doi: 10.6000/1927-5951.2012.02.01.8 |
|
2012 Journal Article Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinomaSundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M. and Thompson, J. F. (2012). Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. Clinical Oncology, 24 (9), E131-E136. doi: 10.1016/j.clon.2012.04.007 |
|
2012 Journal Article Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trialChang, Anne B., Grimwood, Keith, Robertson, Colin F., Wilson, Andrew C., van Asperen, Peter P., O'Grady, Kerry-Ann F., Sloots, Theo P., Torzillo, Paul J., Bailey, Emily J., Mccallum, Gabrielle B., Masters, Ian B., Byrnes, Catherine .A, Buntain, Helen M., Morris, Peter S., Mackay, Ian M. and Chatfield, Mark D. (2012). Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trial. Trials, 13 (156) 156, 156-1-156-9. doi: 10.1186/1745-6215-13-156 |
|
2012 Journal Article High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapySavdie, Richard, Horvath, Lisa G., Benito, Ruth Pe, Rasiah, Krishan K., Haynes, Anne-Maree, Chatfield, Mark, Stricker, Phillip D., Turner, Jennifer J., Delprado, Warwick, Henshall, Susan M., Sutherland, Robert L. and Kench, James G. (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109 (12), 1794-1800. doi: 10.1111/j.1464-410X.2011.10572.x |
|
2012 Conference Publication Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)Sjoquist, Katrin Marie, Lee, Chee, Lord, Sally, Chatfield, Mark D., Friedlander, Michael, Simes, John and Marschner, Ian (2012). Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901)Davis, Ian D., Gebski, Val, Chatfield, Mark D., Grimison, Peter S., Kannourakis, George, Boland, Amy L., Thompson, Jennifer and Stockler, Martin R. (2012). EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (ANZUP trial 0901). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Journal Article HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer CentreWhalley, Deborah, Patanjali, Nitya, Jackson, Michael, Lovett, Aimee, Chatfield, Mark and Hruby, George (2012). HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology, 56 (2), 220-226. doi: 10.1111/j.1754-9485.2012.02358.x |
|
2012 Conference Publication Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trialsGrimison, Peter S., Chatfield, Mark D., Mazhar, Danish, Toner, Guy C., Chester, John D., Stockler, Martin R., Stark, Daniel P., Thomson, Damien B., Shamash, Jonathan, Friedlander, Michael, White, Jeff, Gebski, Val, Wason, James, Boland, Amy L., Rimmer, Yvonne L., McDonald, Angus, Gurney, Howard, Rosenthal, Mark, Singhal, Nimit and Williams, Michael V. (2012). Accelerated BEP for metastatic germ cell tumors: Combined analysis of Australian and UK phase I/II trials. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2011 Journal Article Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural PneumonectomyKao, Steven Chuan-Hao, Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola J., Yan, Tristan D., Vardy, Janette, Clarke, Stephen, van Zandwijk, Nico and McCaughan, Brian (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6 (11), 1923-1929. doi: 10.1097/JTO.0b013e31822a3740 |
|
2011 Conference Publication Factors Affecting Time From Surgery to Adjuvant Chemotherapy for Early Breast Cancer in a Rural and Urban Medical Oncology Unit - a Retrospective Cohort StudyFox, P. N., Chatfield, M. D., Beith, J., Turley, K. and Grimison, P. S. (2011). Factors Affecting Time From Surgery to Adjuvant Chemotherapy for Early Breast Cancer in a Rural and Urban Medical Oncology Unit - a Retrospective Cohort Study. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(11)71216-3 |
|
2011 Conference Publication Patterns of Care for Stage 1 Testicular Cancer in Australia in 2010Houghton, B., Stockler, M., Chatfield, M. D., Toner, G., Davis, I. D. and Grimison, P. S. (2011). Patterns of Care for Stage 1 Testicular Cancer in Australia in 2010. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD. |
|
2011 Conference Publication PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARDKao, Steven C., Clarke, Stephen, Chatfield, Mark, Corte, Peter, Clarke, Christopher, Vardy, Janette and Van Zandwijk, Nico (2011). PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP)Kao, Steven C., Klebe, Sonja, Henderson, Douglas W., Reid, Glen, Chatfield, Mark, Armstrong, Nicola, Yan, Tristan, Vardy, Janette, Clarke, Stephen, Van Zandwijk, Nico and Mccaughan, Brian (2011). CALRETININ EXPRESSION IMPROVES THE PREDICTIVE ACCURACY IN SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) UNDERGOING EXTRAPLEURAL PNEUMONECTOMY (EPP). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)Yip, Po Yee, Cooper, Wendy, Mahar, Annabelle, Kench, James, Kohonen-Corish, Maija R. J., Chatfield, Mark, Boulghourjian, Alice, Kennedy, Catherine W., Mccaughan, Brian, Boyer, Michael and Horvath, Lisa (2011). MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication Accelerated BEP for advanced germ cell tumors: An Australian multicenter phase I/II trialGrimison, P. S., Thomson, D. B., Stockler, M. R., Chatfield, M. D., Friedlander, M., Gebski, V., Boland, A. L., Houghton, B. B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. and Toner, G. C. (2011). Accelerated BEP for advanced germ cell tumors: An Australian multicenter phase I/II trial. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4561 |
|
2011 Conference Publication Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi)Long, G. V., Wilmott, J. S., Howle, J. R., Chatfield, M. D., Tembe, V., Thompson, J. F., Hersey, P., Mann, G. J., McArthur, G. A., Rizos, H., Young, R. J., Scurr, L. L., Sharma, R. N., Kefford, R. F. and Scolyer, R. A. (2011). Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.8542 |
|
2011 Conference Publication BRAF mutation by age-decade and body mass index in metastatic melanomaMenzies, A. M., Visintin, L., Chatfield, M. D., Carlino, M. S., Howle, J. R., Scolyer, R. A., Thompson, J. F., Kefford, R. F. and Long, G. V. (2011). BRAF mutation by age-decade and body mass index in metastatic melanoma. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2011 Conference Publication Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC)Mahon, K. L., Chatfield, M. D., Lee-Ng, M., Breit, S. N., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Wykes, R., Henshall, S. M., Sutherland, R. L. and Horvath, L. (2011). Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4598 |
|
2011 Conference Publication A study of <i>methylated glutathione s-transferase 1 (mGSTP1)</i> as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC)Horvath, L., Mahon, K. L., Qu, W., Devaney, J., Chatfield, M. D., Paul, C., Wykes, R., Boyer, M. J., Stockler, M. R., Marx, G. M., Sutherland, R. L. and Clark, S. J. (2011). A study of methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2011.29.15_suppl.4603 |
